Cardiovascular disease as a leading cause of death: how are pharmacists getting involved?

K Mc Namara, H Alzubaidi… - … pharmacy research and …, 2019 - Taylor & Francis
Cardiovascular diseases (CVDs) are a leading cause of death globally. This article explores
the evidence surrounding community pharmacist interventions to reduce cardiovascular …

US pharmacists' effect as team members on patient care: systematic review and meta-analyses

MA Chisholm-Burns, JK Lee, CA Spivey, M Slack… - Medical care, 2010 - journals.lww.com
Background: One approach postulated to improve the provision of health care is effective
utilization of team-based care including pharmacists. Objective: The objective of this study …

Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews

RE Ryan, N Santesso, D Lowe, S Hill… - Cochrane Database …, 2014 - cochranelibrary.com
Background Many systematic reviews exist on interventions to improve safe and effective
medicines use by consumers, but research is distributed across diseases, populations and …

Effectiveness of pharmacist's intervention in the management of cardiovascular diseases

S Omboni, M Caserini - Open Heart, 2018 - openheart.bmj.com
The pharmacist may play a relevant role in primary and secondary prevention of
cardiovascular diseases, mainly through patient education and counselling, drug safety …

Effectiveness of clinical pharmacy services: an overview of systematic reviews (2000–2010)

I Rotta, TM Salgado, ML Silva, CJ Correr… - International journal of …, 2015 - Springer
Background Multiple reviews have evaluated the impact of pharmacist-delivered patient
care on health-related outcomes. However, it is unclear which of the pharmacist-delivered …

Meta‐analysis of the effectiveness of smoking cessation interventions in community pharmacy

M Saba, J Diep, B Saini… - Journal of clinical …, 2014 - Wiley Online Library
What is known and objective With the emerging and promising role of healthcare
professionals in implementing smoking cessation services, community pharmacists, in …

Impact of community pharmacy diabetes monitoring and education programme on diabetes management: a randomized controlled study

M Ali, F Schifano, P Robinson, G Phillips… - Diabetic …, 2012 - Wiley Online Library
Diabet. Med. 29, e326–e333 (2012) Abstract Aims To evaluate the impact of a pharmacist‐
led patient education and diabetes monitoring programme on HbA1c and other …

Medication therapy management services: definitions and outcomes

AN Pellegrino, MT Martin, JJ Tilton, DR Touchette - Drugs, 2009 - Springer
In the US, the Medicare Modernization Act of 2003 required that Medicare Part D insurers
provide medication therapy management (MTM) services (MTMS) to selected beneficiaries …

Pharmacists' interventions in the management of patients with chronic kidney disease: a systematic review

TM Salgado, R Moles, SI Benrimoj… - Nephrology Dialysis …, 2012 - academic.oup.com
Background. Patients with chronic kidney disease have multiple comorbidities and require
complicated therapeutic regimens. The role of pharmacists caring for these patients has …

Expanding the role of community pharmacists: policymaking in the absence of policy-relevant evidence?

E Mossialos, H Naci, E Courtin - Health policy, 2013 - Elsevier
BACKGROUND AND OBJECTIVES: Policies to expand the traditional role of community
pharmacists have been implemented or at least considered in a number of countries, as …